Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Lexapro (escitalopram) - Important Safety Information from Lundbeck (Ireland) Ltd as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
07/12/2011
Problem Or Issue:
Important Safety Information communication from Lundbeck (Ireland) Ltd on the association of Lexapro (escitalopram) with dose-dependent QT interval prolongation.
Important Safety Information - Lexapro
« Back
Date Printed: 08/05/2024